What Your Doctor Isn’t Telling You About Compounded GLP-1s

You got the prescription. Nobody explained what you’re actually injecting.

Compounded GLP-1 medications are prescribed to hundreds of thousands of patients every month. The majority of them receive a vial, a syringe, and instructions — and very little else. No explanation of what compounded means. No transparency on where the medication was made. No conversation about how to verify the pharmacy is legitimate.

This isn’t a scandal. It’s a systemic gap. Physicians prescribe; pharmacies compound; patients inject. The chain works — until it doesn’t. And the patients who get hurt are always the ones who didn’t know what questions to ask.

This guide fixes that. After reading it, you’ll know exactly what compounded means, who regulates it, what to look for in a legitimate pharmacy, and the five questions every patient should ask before their first dose.

The five questions you should ask — and what good answers look like

1. What does “compounded” actually mean for my medication? Compounding means the medication is prepared by a licensed pharmacy to order rather than manufactured commercially. FDA-approved versions (branded Ozempic®, Wegovy®, Mounjaro®) go through rigorous manufacturing oversight. Compounded versions are not FDA-approved for safety, efficacy, or manufacturing quality — but they are legal under specific conditions and regulated by state pharmacy boards and, for 503B facilities, by the FDA itself.
2. What’s the difference between a 503A and 503B pharmacy? 503A pharmacies compound patient-specific prescriptions — regulated by state boards. 503B outsourcing facilities are registered with the FDA, subject to federal inspections, and held to Current Good Manufacturing Practice (cGMP) standards — the same standards applied to commercial drug manufacturers. 503B is the higher bar. Ask which designation your pharmacy holds.
3. Who verifies the purity and potency of what’s in the vial? Reputable compounding pharmacies conduct Certificate of Analysis (CoA) testing on every batch — third-party lab verification that the medication contains what the label says, at the stated concentration, with no harmful contaminants. Ask for the CoA. A legitimate pharmacy will provide it. A pharmacy that can’t or won’t is a red flag.
4. Is the semaglutide or tirzepatide the actual active ingredient? This matters more than it sounds. Some products marketed as “semaglutide” are actually semaglutide salts or derivatives — related compounds that are not the same as pharmaceutical-grade semaglutide. Ask your pharmacy to confirm the specific form of the active ingredient and whether it matches the molecular structure of the pharmaceutical reference standard.
5. Is there a licensed physician who adjusts my dose — or just a prescription? A prescription-only program ends at the vial. A physician-guided program includes ongoing monitoring, dosage titration as your body changes, and a provider who can recognize and respond to adverse effects or sub-optimal response. The medication is one input. The oversight is what makes it safe.

The red flags that separate safe programs from risky ones

The compounded GLP-1 market has legitimate providers and predatory ones. These signals sort them fast.

• Pharmacy credentials that can’t be verified. If a program can’t confirm that its pharmacy is state-licensed — or, where applicable, an FDA-registered 503B outsourcing facility — you have no way to verify quality standards or inspection history. Unverifiable credentials are the loudest possible warning sign.
• No Certificate of Analysis available. Every legitimate batch should have a third-party CoA confirming purity and potency. If your pharmacy can’t produce one, you don’t know what’s in the vial. This is non-negotiable.
• Subscription model with no physician oversight. Programs that auto-ship refills without a prescriber reviewing your response are dispensing, not treating. Dose titration requires a physician. Anyone shipping semaglutide on autopilot is cutting a critical safety step.
• Unusually low prices with no transparency. Legitimate compounding has real costs — USP-grade API, testing, sterile preparation, physician oversight. Prices significantly below market suggest corners are being cut somewhere in the chain. Know where.
• “Semaglutide salts” or unspecified derivatives. Some online providers use alternative forms of semaglutide that are not pharmaceutical-grade. Ask explicitly whether the active ingredient is the same molecular form as the FDA-approved reference standard.

What a transparent program looks like vs. what most patients actually get

Use this checklist when evaluating any compounded GLP-1 program — including ours.

You’re injecting this into your body. Demand to know everything.

The compounded GLP-1 market is large, largely unregulated at the consumer level, and growing fast. The patients who get hurt are almost always the ones who didn’t ask — not because they didn’t care, but because nobody told them what to ask.

You now know the five questions. You know what a Certificate of Analysis is. You know the difference between 503A and 503B. You know the red flags. Use that.

CoraDoc was built precisely because the standard in this space is too low. Licensed, verified pharmacy partners. Physician oversight at every dose. LegitScript certification. No subscriptions. No hidden fees. The Triple Free Promise: free visit, free shipping, free supplies. Because if we can’t answer your questions clearly, we shouldn’t be treating you.

✓ LegitScript certified   ✓ Licensed pharmacy partners   ✓ All 50 states   ✓ No subscription

Compounded semaglutide and tirzepatide are not the same as FDA-approved branded medications. Regulations governing compounding pharmacies are subject to change. Ozempic®, Wegovy®, and Mounjaro® are trademarks of their respective owners; CoraDoc is not affiliated with or endorsed by them.

Educational only — not medical advice. This guide is for general information and is not a substitute for consultation with a licensed healthcare provider. It does not diagnose, treat, or guarantee any outcome. Statistics cited are approximate and drawn from published clinical literature.

Prescription products are dispensed only if a licensed provider determines they’re appropriate for you. Certain medications offered through CoraDoc are compounded and are not reviewed or approved by the FDA for safety, efficacy, or manufacturing quality. Semaglutide and tirzepatide are not for everyone; potential side effects should be discussed with a provider. Individual results vary.